Anticorps Monoclonal anti-CD154
CD154 Monoclonal Antibody for FC
Hôte / Isotype
Mouse / IgG1, kappa
Réactivité testée
Humain, primates non humains
Applications
FC
Conjugaison
Non conjugué
CloneNo.
24-31
N° de cat : 65156-1-Ig
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en cytométrie | CMSP humaines, |
Dilution recommandée
Application | Dilution |
---|---|
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Informations sur le produit
65156-1-Ig cible CD154 dans les applications de FC et montre une réactivité avec des échantillons Humain, primates non humains
Réactivité | Humain, primates non humains |
Hôte / Isotype | Mouse / IgG1, kappa |
Clonalité | Monoclonal |
Type | Anticorps |
Immunogène | protéine de fusion CD154 humaine |
Nom complet | CD40 ligand |
Masse moléculaire calculée | 261 aa, 29 kDa |
Numéro d’acquisition GenBank | BC071754 |
Symbole du gène | CD40LG |
Identification du gène (NCBI) | 959 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purifié par chromatographie d'affinité par protéine A |
Tampon de stockage | PBS avec azoture de sodium à 0,1 %. |
Conditions de stockage | Store at 2-8°C. Stable for one year after shipment. |
Informations générales
The CD40 ligand (CD40L, TRAP, CD154), a member of the TNF superfamily of ligands, is expressed as either a 33-kd transmembrane homologue or 18-kd soluble form (sCD154). CD40L is primarily expressed on activated CD4+ T cells and on a small proportion of CD8+ T cells and platelets. It binds to CD40 on antigen-presenting cells (APC), which leads to many effects depending on the target cell type. It has been suggested that CD40/CD40L interactions regulate oxidative stress and affect various signaling pathways in both the immunological and the cardiovascular systems. The CD40/CD40L system is also involved in tumorigenesis. Its expression is tightly regulated, and abnormal levels of CD40L are associated with the pathogenesis of atheromatous plaque destabilization and thrombotic events. Multiple mutations in CD40LG gene have been identified that are associated with hyper-IgM immunodeficiency syndrome type 1.
Protocole
Product Specific Protocols | |
---|---|
FC protocol for CD154 antibody 65156-1-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |